Modelling the Cost Effectiveness of Rituximab in Chronic...

PharmacoEconomics 2014 / 02 Vol. 32; Iss. 2

Modelling the Cost Effectiveness of Rituximab in Chronic Lymphocytic Leukaemia in First-Line Therapy and Following Relapse

Adena, Michael, Houltram, Jennifer, Mulligan, Stephen P., Todd, Carlene, Malanos, Grace
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
32
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-013-0125-7
Date:
February, 2014
File:
PDF, 587 KB
english, 2014
Conversion to is in progress
Conversion to is failed